Research Tools

The CSER Information Seeking Measure (two versions) is a single-item measure that assesses the sources of information that patients think they will be likely to use to obtain further information about their genetic test results. The measure should be administered post-return of results.

This physician consent form was approved by the Institutional Review Board for the Baylor College of Medicine and Affiliated Hospitals for use in the Incorporation of Genomic Sequencing into Pediatric Cancer Care Study. The purpose of the study was learn how to report and use clinical exome sequencing test results for childhood cancer patients.

This draft age of majority consent form was designed to be used in the Incorporation of Genomic Sequencing into Pediatric Cancer Care Study. The purpose of the study was learn how to report and use clinical exome sequencing test results for childhood cancer patients.

The purpose of the MedSeq Project was to develop a process for a process for integrating information obtained from whole genome sequencing into clinical practice and to explore how physicians and their patients understand and utilize this information. This consent for primary care physicians provides information on the purpose of the study, study procedures, risks and possible benefits of particpating, payment, contact information for questions or concerns, and privacy protections.

The purpose of the MedSeq Project was to develop a process for a process for integrating information obtained from whole genome sequencing into clinical practice and to explore how physicians and their patients understand and utilize this information. This cardiology patient consent form provides information on the purpose of the study, study procedures, risks and possible benefits of particpating, contact information for questions or concerns, and privacy protections.

The purpose of the MedSeq Project was to develop a process for a process for integrating information obtained from whole genome sequencing into clinical practice and to explore how physicians and their patients understand and utilize this information. This primary care patient consent form provides information on the purpose of the study, study procedures, risks and possible benefits of particpating, contact information for questions or concerns, and privacy protections.

The purpose of PediSeq: The Pediatric Genetic Sequencing Project was to identify best practices for educating patients about exome and genome sequencing, determining the sequencing data relevent to patients, and returning results. This informed consent form and HIPAA authorization is appropriate for use with parents of study participants and children capable to providing assent. It contains consent to future analyses of test results, use of data or specimens for future research, future contact, and photgraphs, in addition to consent to study participation.

This consent form for adult patients or parents of minor patients (with child assent) includes standard consent language and the ability for participants to “opt out” of learning about genome sequencing results, unless a result is of urgent importance to their health.

This consent form for the CanSeq study included permission to perform genetic tests on tissue specimens that had already been collected and stored as part of clinical care or other research studies the person participated in.

The Institutional and Professional Impact of Genomic Sequencing in Cancer Care examined the impact of the use of whole-exome sequencing (WES) on physicians and institutional systems at the Dana-Farber Cancer Institute (DFCI). This consent form is for clinically active oncologists involved in the care of cancer patients and members of the Cancer Genomics Evaluation Committee (CGEC), which was established to guide the incorporation of WES into cancer care.